1 Mailankody S,Pfeiffer RM,Kristinsson SY,et al.Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease(MGUS)[J].Blood,2011,118(15):4086-4092. 2 Tzeng HE,Lin CL,Tsai CH,et al.Time trend of multiple myeloma and associated secondary primary malignancies in Asian patients:a Taiwan population-based study[J].PloS One,2013,8(7):e68041. 3 The Finnish Leukaemia Group.Acute leukaemia and other secondary neoplasms in patients treated with conventional chemotherapy for multiple myeloma:a Finnish Leukaemia Group study[J].Eur J Haematol,2000,65(2):123-127. 4 Hasskarl J,Ihorst G,DE Pasquale D,et al.Association of multiple myeloma with different neoplasms:systematic analysis in consecutive patients with myeloma[J].Leuk Lymphoma,2011,52(2):247-259. 5 Barlogie B,Tricot G,Haessler J,et al.Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization:the Arkansas experience in more than 3,000 patients treated since 1989[J].Blood,2008,111(1):94-100. 6 Landgren O,Thomas A,Mailankody S.Myeloma and second primary cancers[J].N Engl J Med,2011,365(23):2241-2242. 7 Allan JM,Travis LB.Mechanisms of therapy-related carcinogenesis[J].Nat Rev Cancer,2005,5(12):943-955. 8 Landgren O,Ma W,Kyle RA,et al.Polymorphism of the erythropoietin gene promotor and the development of myelodysplastic syndromes subsequent to multiple myeloma[J].Leukemia,2012,26(4):844-845. 9 郭秀臣,全丽娜,李红,等.多发性骨髓瘤患者骨髓中Treg细胞与预后相关性研究[J].实用肿瘤学杂志,2014,28(1):54-58. 10 Thomas A,Mailankody S,Korde N,et al.Second malignancies after multiple myeloma:from 1960s to 2010s[J].Blood,2012,119(12):2731-2737. 11 Larson RA,Le Beau MM.Prognosis and therapy when acute promyelocytic leukemia and other "good risk" acute myeloid leukemias occur as a therapy-related myeloid neoplasm[J].Mediterr J Hematol Infect Dis,2011,3(1):e2011032. |